Articles From: Colgate's adjusted profit rises 6%, meets views to CollabRx, Inc. Schedules First Quarter Fiscal Year 2014 Financial Conference Call and Business Update


LONDON (MarketWatch) -- Colgate-Palmolive Co.
Sign-up for Colgate's adjusted profit rises 6%, meets views investment picks
2013/11/7
WEST LAFAYETTE, Ind., Nov.
Sign-up for Colin Goddard, Ph.D., Joins the Endocyte Board of Directors investment picks
2013/9/11
FRANKFURT, Germany , Sept.
Sign-up for Collaboration between Daimler and Renault-Nissan advances globally, CEOs say investment picks
2013/10/16
Adesto Technologies , a memory solutions provider delivering innovative products for code and data storage applications, and Nordion , with global expertise in the design and construction of commercial gamma irradiation systems, today announced the successful completion of gamma irradiation testing of Adesto’s CBRAM non-volatile memory products.
Sign-up for Collaboration with Adesto Technologies and Nordion Confirms Gamma Irradiation Tolerance of CBRAM® Non-Volatile Memory investment picks
2013/10/7
LONDON , Oct.
Sign-up for Collabrium Japan Acquisition Corporation Receives Nasdaq Notification Letter investment picks
2014/4/16
SAN FRANCISCO, Calif., April 16, 2014 (GLOBE NEWSWIRE) -- via PRWEB - CollabRx, Inc. (NASDAQ: CLRX) , a leading provider of software and IT systems that support clinical decision-making in oncology, and Affymetrix, Inc. (NASDAQ: AFFX) , an industry leader in genomics analysis, today announced an agreement to optimize the use of CollabRx's Genetic Variant Annotation (GVA) Service™ in connection with Affymetrix' OncoScan™ FFPE Assay Kit and CytoScan® Cytogenetics Suite for analysis of gene copy number variation (CNV) in cancer research.
Sign-up for CollabRx and Affymetrix Partner To Develop Analytical Tools For Integrated Clinical Cancer Panels investment picks
2014/1/27
SAN FRANCISCO, Jan.
Sign-up for CollabRx and CellNetix Partner to Advance Molecular Testing in Oncology investment picks
2013/12/11
SAN FRANCISCO, Dec.
Sign-up for CollabRx and Cynvenio Partner in Molecular Diagnostics for Cancer investment picks
2014/4/2
SAN FRANCISCO, Calif., April 2, 2014 (GLOBE NEWSWIRE) -- via PRWEB - CollabRx, Inc. (NASDAQ: CLRX) , a data analytics company focused on informing clinical decision-making in molecular medicine, and The Jackson Laboratory (JAX), an independent, nonprofit biomedical research institution with a staff of over 1,500 employees, today announced a multi-year agreement to access CollabRx technology and content resources in support of the clinical interpretation of genetic sequencing-based tests provided by JAX.
Sign-up for CollabRx and The Jackson Laboratory Partner in Molecular Diagnostics for Cancer investment picks
2013/8/13
SAN FRANCISCO, Aug.
Sign-up for CollabRx Announces Oncology-Specific Mobile App With Leading Site for Healthcare Professionals, MedPage Today investment picks
2014/3/5
SAN FRANCISCO, March 5, 2014 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX) today announced the appointment of Clifford Baron, PhD as Vice President and Chief Operating Officer.
Sign-up for CollabRx Appoints Clifford Baron as Chief Operating Officer investment picks
2013/9/4
SAN FRANCISCO, Sept.
Sign-up for CollabRx Appoints George Lundberg, M.D. as Chief Medical Officer investment picks
2014/4/8
SAN FRANCISCO, April 8, 2014 (GLOBE NEWSWIRE) -- via PRWEB - CollabRx, Inc. (Nasdaq:CLRX) today announced the appointment of Paul R.
Sign-up for CollabRx Appoints Paul Billings, MD, PhD to Board of Directors investment picks
SAN FRANCISCO, Aug.
Sign-up for CollabRx Featured in Forbes Article: "Can We Build A Kickstarter For Cancer?" investment picks
2013/8/6
SAN FRANCISCO, Aug.
Sign-up for CollabRx Featured on NBC News (VIDEO) investment picks
2014/1/15
SAN FRANCISCO, Jan.
Sign-up for CollabRx Launches New Web App for Cynvenio's ClearID Breast Cancer Patients investment picks
SAN FRANCISCO, Aug.
Sign-up for CollabRx Reports First Quarter Fiscal Year 2014 Financial Results investment picks
2013/11/13
SAN FRANCISCO, Nov.
Sign-up for CollabRx Reports Second Quarter Fiscal Year 2014 Financial Results investment picks
2014/2/11
SAN FRANCISCO, Feb.
Sign-up for CollabRx Reports Third Quarter Fiscal Year 2014 Financial Results investment picks
2013/7/25
SAN FRANCISCO, July 25, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX) , a data analytics company focused on informing clinical decision making in molecular medicine, announced it has engaged Hayden IR, a 15-year-old, highly recognized, national investor relations firm, to raise the visibility of CollabRx and strengthen its relationships with the investment community "Over the past year, we have strengthened our financial position and transformed our overall business from development stage to commercialization phase, with our first substantial revenue coming in the fourth quarter of our fiscal 2013," said Thomas R.
Sign-up for CollabRx Retains Hayden IR to Develop Strategic Investor Relations Program investment picks
2013/11/11
SAN FRANCISCO, Nov.
Sign-up for CollabRx Teams With Quest Diagnostics in Clinical Genetic Sequencing investment picks
SAN FRANCISCO, Sept.
Sign-up for CollabRx to Present at LD MICRO Invitational on October 2nd investment picks
SAN FRANCISCO, July 30, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX) , a data analytics company focused on informing clinical decision making in molecular medicine, announces that Thomas R.
Sign-up for CollabRx to Present at the 2013 Southern California Investor Conference investment picks
SAN FRANCISCO, Nov.
Sign-up for CollabRx to Present at the LD MICRO Sixth Annual Conference investment picks
2014/1/21
SAN FRANCISCO, Jan.
Sign-up for CollabRx to Present at the Sixth Annual Personalized Medicine World Conference investment picks
SAN FRANCISCO, July 31, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX) , a data analytics company focused on genomics, today announced that it will hold an investor conference call on August 13, 2013, to discuss the Company's financial results for the first quarter of fiscal 2014 and to provide an update about the business in the current fiscal year.
Sign-up for CollabRx, Inc. Schedules First Quarter Fiscal Year 2014 Financial Conference Call and Business Update investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Colgate's adjusted profit rises 6%, meets views to CollabRx, Inc. Schedules First Quarter Fiscal Year 2014 Financial Conference Call and Business Update
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity